摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

phenylmethyl 2-(4-chloro-6,6-dimethyl-5,6,7,8-tetrahydroquinazolin-2-yl)pyrrolidine-1-carboxylate | 1256956-61-2

中文名称
——
中文别名
——
英文名称
phenylmethyl 2-(4-chloro-6,6-dimethyl-5,6,7,8-tetrahydroquinazolin-2-yl)pyrrolidine-1-carboxylate
英文别名
Benzyl 2-(4-chloro-6,6-dimethyl-5,6,7,8-tetrahydroquinazolin-2-yl)pyrrolidine-1-carboxylate;benzyl 2-(4-chloro-6,6-dimethyl-7,8-dihydro-5H-quinazolin-2-yl)pyrrolidine-1-carboxylate
phenylmethyl 2-(4-chloro-6,6-dimethyl-5,6,7,8-tetrahydroquinazolin-2-yl)pyrrolidine-1-carboxylate化学式
CAS
1256956-61-2
化学式
C22H26ClN3O2
mdl
——
分子量
399.92
InChiKey
IBEVMRJIEPMZGZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    28
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    55.3
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture
    申请人:Rice Kenneth D.
    公开号:US20140080810A1
    公开(公告)日:2014-03-20
    The invention is directed to Compounds of Formula I: (I) and pharmaceutically acceptable salts or solvates thereof, as well as methods of treating using the compounds, methods for screening for inhibitor compounds and methods for identifying treatment regimens.
    本发明涉及化合物I式:(I)及其药学上可接受的盐或溶剂化物,以及使用该化合物进行治疗的方法,筛选抑制剂化合物的方法和确定治疗方案的方法。
  • BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES
    申请人:Exelixis, Inc.
    公开号:EP2432779A1
    公开(公告)日:2012-03-28
  • BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE
    申请人:Exelixis, Inc.
    公开号:EP2640366A2
    公开(公告)日:2013-09-25
  • US8648066B2
    申请人:——
    公开号:US8648066B2
    公开(公告)日:2014-02-11
  • [EN] BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES<br/>[FR] INHIBITEURS DE PI3K/MTOR À BASE DE BENZOXAZÉPINES POUR LUTTER CONTRE LES MALADIES PROLIFÉRATIVES
    申请人:EXELIXIS INC
    公开号:WO2010135524A1
    公开(公告)日:2010-11-25
    The invention is directed to compounds of formula (I), and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds.
查看更多